Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$257,286 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Derivatives in KRYS
reported options exposure · as of Jun 30, 2026CallValue
$9,923,589
CallShares
26,700
PutValue
$297,336
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in KRYS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,923,589 | 26,700 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $297,336 | 800 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $2,428,208 | 9,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $257,286 | 996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $519,706 | 2,108 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,202,875 | 6,814 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,611,993 | 11,727 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,995,527 | 49,892 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,163,513 | 7,427 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,701,252 | 9,346 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,028,487 | 11,046 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,595,064 | 82,027 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,329,512 | 67,141 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,467,812 | 55,757 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,149,933 | 9,795 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $447,935 | 5,595 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $507,008 | 6,400 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $564,570 | 8,100 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $531,846 | 8,100 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $253,450 | 3,809 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $708,541 | 13,571 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $492,320 | 7,240 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||